Home | Infections | Hepatitis


Worldwide treatment of hepatitis C could be within sight at the right cost

A 12-week course of the new drug sofosbuvir in the US is priced at as much as $84,000 per person ...

Berry scare: here’s what you need to know about hepatitis A

OPINION: School students in Victoria, South Australia, and Queensland are the latest group thought to have eaten frozen berries linked to hepatitis ...

Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention

Loyola’s HepNet study reveals high frequency of active infection and multiple risk factors in Ghana ... Full story

Reactivation of Hepatitis B Can Be Prevented and Treated During Immunosuppressive Drug Therapy

New American Gastroenterological Association Guidelines Provide Guidance on Managing the Clinical Problem ... Full story

Potential cure for hepatitis B enters phase 1/2a clinical trial

A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus (HBV) infection is now recruiting patients for a phase I/2a clinical trial. ... Full story

Simeprevir-Based Therapy Offers Patients in Developing Countries a Cost-Effective Alternative in Treatment of Hepatitis C

PHILADELPHIA — Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries. Further, simeprevir proved to be simpler for patients and had fewer adverse events. The complete study is now available online and is scheduled to publish in January 2015 in The Lancet Infectious Diseases. ... Full story

New vaccine generates strong immune response against hepatitis C

A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease. ... Full story

MIT Medical sets third-straight, single-day record for flu shots

Kim Schive | MIT Medical - It didn’t start out looking like a record-shattering kind of day. ... Full story

SLU Researcher to Study New Hepatitis C Medication in Children

New combination of drugs could decrease side effects, increase cure rate ... Full story

Genetic 'instruction set' for antibodies knocks down hepatitis C in mice

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. ... Full story

1 2 3 4 5 6 7 next total: 64 | displaying: 1 - 10